Literature DB >> 2596763

Comparison of Alternaria tenuis extracts prepared from different raw materials.

R Wahl1, J D Oliver, P R Hauck, H G Winter, H J Maasch.   

Abstract

Alternaria extracts, prepared from three different sources under the same conditions, were compared by several biochemical/immunochemical methods. Two raw materials (A,G) contained mostly mycelia. The third raw material (C) contained mycelia (35%) and spores (65%). Extracts A and G were different in total allergenic potency, antigen/allergen pattern, and in the Alt 1 content. Extract C was of similar total allergenic potency as extract A but showed a somewhat different antigen/allergen pattern and a different Alt 1 content. Although there were some compositional differences among the extracts, all extracts regardless of source materials (spores and mycelia) demonstrated strong RAST inhibition activity and parallelism of the inhibition curves.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2596763

Source DB:  PubMed          Journal:  Ann Allergy        ISSN: 0003-4738


  6 in total

1.  The manufacture of allergenic extracts in North America.

Authors:  P R Hauck; S Williamson
Journal:  Clin Rev Allergy Immunol       Date:  2001-10       Impact factor: 8.667

Review 2.  Laboratory methods for allergen extract analysis and quality control.

Authors:  T J Grier
Journal:  Clin Rev Allergy Immunol       Date:  2001-10       Impact factor: 8.667

Review 3.  Standardization of fungal allergens.

Authors:  R K Bush; J W Yunginger
Journal:  Clin Rev Allergy       Date:  1987-02

Review 4.  Mold allergens in respiratory allergy: from structure to therapy.

Authors:  Teresa E Twaroch; Mirela Curin; Rudolf Valenta; Ines Swoboda
Journal:  Allergy Asthma Immunol Res       Date:  2015-03-11       Impact factor: 5.764

Review 5.  Fungal allergens.

Authors:  W E Horner; A Helbling; J E Salvaggio; S B Lehrer
Journal:  Clin Microbiol Rev       Date:  1995-04       Impact factor: 26.132

6.  Preparation of chemically stable allergen-specific sublingual immunotherapy from Egyptian allergens.

Authors:  Mohammed A Abu El-Enin; Eman M Rabie Shehab El-Din; Heba Wagih Abdelwahab; Amina Abd El-Maksoud; Abeer M Abd El-Aziz; Mona I Shaaban; Ahmed Nader Attia; Wafaa A Aboukamar; Sanaa Mohei-Aldin; Fathalla Belal
Journal:  J Clin Lab Anal       Date:  2022-02-11       Impact factor: 2.352

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.